Bone marrow injection may tame arthritis after failed ACL surgery
NCT ID NCT06311513
First seen Nov 20, 2025 · Last updated May 22, 2026 · Updated 23 times
Summary
This study tests whether a concentrated bone marrow injection (cBMA) given during revision ACL surgery can reduce knee pain and inflammation from post-traumatic osteoarthritis. About 40 adults aged 18-55 who need a second ACL repair will be randomly assigned to get cBMA or not. Researchers will track pain, function, and inflammatory markers for two years to see if cBMA helps control arthritis symptoms.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for ACL INJURY are added.
Genom att skicka in godkänner du våra Användarvillkor
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
Genom att skicka in godkänner du våra Användarvillkor
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
Emory Orthopaedics & Spine Center
RECRUITINGAtlanta, Georgia, 30097, United States
-
Hospital for Special Surgery
RECRUITINGNew York, New York, 10021, United States
Contact Phone: •••-•••-•••• Email: •••••@•••••
Contact
Conditions
Explore the condition pages connected to this study.